Hi
@Mujtabazafar ,
Thanks so much for your reply.
Appreciate the effort that you have gone too.
Now what you need to do to your baseline projections is calibrate them with some comparable companies, on a like for like
(granted that there will not be companies researching exactly the same therapies but you could use a similar psychedelic trial to our psychedelic trial for instance.)
Here is a website that might assist you with that one
https://psilocybinalpha.com/data/psychedelic-drug-development-tracker
Check a comparable company - market cap
For the other therapies it's a bit difficult but you could use the TAM for each therapy perhaps?
Also read this article and in particular review Joel Latham's direct quotes regarding comparable companies.
Click here to view the referenceGood luck
@Mujtabazafar